NutriBand (NTRB) Preferred Shares (2025 - 2026)
NutriBand's (NTRB) quarterly Preferred Shares came in at $3009.0 in Q1 2026, little changed quarter-over-quarter from $3009.0 in Q4 2025.
NutriBand (NTRB) Preferred Shares (2025 - 2026) Analysis & Trends
NutriBand has disclosed Preferred Shares across 2 years of filings, most recently posting $3009.0 for Q1 2026.
- Preferred Shares for Q1 2026 came in at $3009.0, changed N/A year-over-year; the trailing twelve-month figure through Jan 2026 was $3009.0 (changed N/A YoY), and the FY2026 annual result was $3009.0, changed N/A from the prior year.
- Preferred Shares came in at $3009.0 for Q1 2026 at NutriBand, roughly flat from $3009.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $3009.0 in Q3 2025 to a low of $3009.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | NutriBand | 41.21 Mn | 36.63 Mn | 88,941.00 | 3,009.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 3,009.00 |
| Oct 31, 2025 | 3,009.00 |
| Jul 31, 2025 | 3,009.00 |